Published on 17th January 2014

Bioquell PLC ("Bioquell") (LSE symbol: BQE) - provider of specialist microbiological control technologies to the international Healthcare, Life Sciences & Defence markets; and specialist testing services in the UK via its TRaC division, today announces an update on its trading performance prior to entering the closed period ahead of the preliminary results for the year to 31 December 2013.

Trading remained broadly consistent with that disclosed in the Interim Management Statement on 15 November, 2013.

We estimate that orders for the year ended 31 December, 2013 will be approximately £48.7 million (2012: £44.6 million), an increase in the year of some 9%; and revenues will be approximately £44.6 million (2012: 41.0 million), an increase in the year of some 9%.

The preliminary results for the year ended 31 December, 2013 will be announced on 18 March, 2014.

Downloads
  • Pre-close update on the year ended 31 December 2013
distributed by